European Journal of Cancer, 0959-8049

Journal

More filtering options
  1. 1992
  2. Elevation of ADP-ribosylation as an indicator of mononuclear leucocyte responsiveness in breast cancer patients treated with tamoxifen

    Pero, R. W., Håkan Olsson, Killander, F. & Troll, W., 1992 Jan 1, In : European Journal of Cancer. 28, 11, p. 1803-1806 4 p.

    Research output: Contribution to journalArticle

  3. Intravenous clodronate for the treatment of hypercalcaemia in breast cancer patients with bone metastases-A prospective randomised placebo-controlled multicentre study

    Rotstein, S., Glas, U., Mikael Eriksson, Pfeiffer, P., Hansen, J., Söderqvist, J., Bandmann, U. & Strid, S., 1992 Jan 1, In : European Journal of Cancer. 28, 4-5, p. 890-893

    Research output: Contribution to journalArticle

  4. 1993
  5. Rheumatoid arthritis as a risk factor for multiple myeloma: A case-control study

    Mikael Eriksson, 1993 Jan 1, In : European Journal of Cancer. 29, 2, p. 259-263

    Research output: Contribution to journalArticle

  6. 1994
  7. Cathepsin D, both a prognostic factor and a predictive factor for the effect of adjuvant tamoxifen in breast cancer. South Sweden Breast Cancer Group

    Mårten Fernö, Bo Baldetorp, Åke Borg, Brouillet, J. P., Håkan Olsson, Rochefort, H., Sellberg, G., Sigurdsson, H. & Dick Killander, 1994, In : European Journal of Cancer. 30a, 14, p. 2042-2048

    Research output: Contribution to journalArticle

  8. Efficacy and tolerability of tropisetron in comparison with a combination of tropisetron and dexamethasone in the control of nausea and vomiting induced by cisplatin-containing chemotherapy

    Sorbe, B., T Högberg, Himmelmann, A., Schmidt, M., Räisänen, I., Stockmeyer, M. & de Bruijn, K. M., 1994, In : European Journal of Cancer. 30, 5, p. 629-34 6 p.

    Research output: Contribution to journalArticle

  9. Hypersomy of chromosome 15 with retrovirally rearranged c-myc, loss of germline c-myc and IgK/c-myc juxtaposition in a macrophage-monocytic tumour line

    Imreh, S., Wang, Y., Panda, C. K., Babonits, M., H Axelson, Silva, S., Szeles, A., Wiener, F. & Klein, G., 1994, In : European Journal of Cancer. 30A, 7, p. 994-1002 9 p.

    Research output: Contribution to journalArticle

  10. At what age do sunburn episodes play a crucial role for the development of malignant melanoma

    Westerdahl, J., H. Olsson & C. Ingvar, 1994 Jan 1, In : European Journal of Cancer. 30, 11, p. 1647-1654 8 p.

    Research output: Contribution to journalArticle

  11. 1995
  12. A Phase I/II Evaluation of Metoclopramide as a Radiosensitiser in Patients with Inoperable Squamous Cell Carcinoma of the Lung

    Kjellén, E., Pero, R., Eva Brun, Ewers, S-B., Olof Jarlman, Tommy Knöös, Per Malmström, Jan Tennvall, Dick Killander, Olsson, A., Sheng, Y. & Johan Wennerberg, 1995, In : European Journal of Cancer. 31, 13-14, p. 2196-2202

    Research output: Contribution to journalArticle

  13. Effects of intrapleural mitoxantrone and mepacrine on malignant pleural effusion--a randomised study

    Leif Bjermer, Gruber, A., Sue-Chu, M., Sandström, T., Eksborg, S. & Henriksson, R., 1995, In : European Journal of Cancer. 31, 13-14, p. 2203-2208

    Research output: Contribution to journalArticle

  14. The amino-terminal phosphorylation sites of C-MYC are frequently mutated in Burkitt's lymphoma lines but not in mouse plasmacytomas and rat immunocytomas

    H Axelson, Henriksson, M., Wang, Y., Magnusson, K. P. & Klein, G., 1995 Nov, In : European Journal of Cancer. 31A, 12, p. 2099-104 6 p.

    Research output: Contribution to journalArticle

  15. 1996
  16. 1997
  17. Tumor Biological Features of BRCA1-Induced Breast Cancer

    Johannsson, O. T., Idvall, I., Andersson, C., Åke Borg, Barkardóttir, R. B., Egilsson, V. & Håkan Olsson, 1997, In : European Journal of Cancer. 33, 3, p. 362-371

    Research output: Contribution to journalArticle

  18. Tumour biological features of BRCA1-induced breast and ovarian cancer

    Jóhannsson, O. T., Idvall, I., Anderson, C., Åke Borg, Barkardóttir, R. B., Egilsson, V. & Håkan Olsson, 1997 Mar, In : European Journal of Cancer. 33, 3, p. 362-371

    Research output: Contribution to journalArticle

  19. 1998
  20. BRCA1-positive patients are small for gestational age compared with their unaffected relatives

    H Jernström, Johannsson, O., A Borg, Ivarsson, H. & H Olsson, 1998 Feb, In : European Journal of Cancer. 34, 3, p. 368-71

    Research output: Contribution to journalArticle

  21. 1999
  22. Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers

    Johannsson, O., Niklas Loman, Möller, T., Ulf Kristoffersson, Åke Borg & Håkan Olsson, 1999, In : European Journal of Cancer. 35, 8, p. 1248-1257

    Research output: Contribution to journalArticle

  23. Perivascular cell protection in vivo and increased cell survival in vitro by the antihypertensive agent carvedilol following radiation

    Jonsson, O. E., Leif Bjermer, Denekamp, J., Grankvist, K. & Henriksson, R., 1999, In : European Journal of Cancer. 35, 8, p. 1268-1273

    Research output: Contribution to journalArticle

  24. Familial and hereditary prostate cancer in southern Sweden. A population-based case-control study

    Bratt, O., U Kristoffersson, Lundgren, R. & Håkan Olsson, 1999 Feb, In : European Journal of Cancer. 35, 2, p. 272-7 6 p.

    Research output: Contribution to journalArticle

  25. 2000
  26. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients

    Bjordal, K., de Graeff, A., Fayers, P. M., Hammerlid, E., van Pottelsberghe, C., Curran, D., Ahlner-Elmqvist, M., Maher, E. J., Meyza, J. W., Bredart, A., Soderholm, A. L., Arraras, J. J., Feine, J. S., Abendstein, H., Morton, R. P., Pignon, T., Huguenin, P., Bottomly, A. & Kaasa, S., 2000, In : European Journal of Cancer. 36, 14, p. 1796-1807

    Research output: Contribution to journalArticle

  27. Five-year results in Ewing's sarcoma. The Scandinavian Sarcoma Group experience with the SSG IX protocol

    Elomaa, I., Blomqvist, C. P., Saeter, G., Akerman, M., Stenwig, E., Thomas Wiebe, Bjork, O. & Thor Alvegård, 2000, In : European Journal of Cancer. 36, 7, p. 875-880

    Research output: Contribution to journalArticle

  28. Prognosis and clinical presentation of BRCA2-associated breast cancer

    Niklas Loman, Johannsson, O., Pär-Ola Bendahl, Dahl, N., Einbeigi, Z., Gerdes, A., Åke Borg & Håkan Olsson, 2000, In : European Journal of Cancer. 36, 11, p. 1365-1373

    Research output: Contribution to journalArticle

  29. Involvement of adenomatous polyposis coli (APC)/beta-catenin signalling in human breast cancer

    Jönsson, M., Borg, A., M Nilbert & Andersson, T., 2000 Jan, In : European Journal of Cancer. 36, 2, p. 242-8 7 p.

    Research output: Contribution to journalArticle

  30. Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer

    Bratt, O., Damber, J. E., Emanuelsson, M., U Kristoffersson, Lundgren, R., Håkan Olsson & Grönberg, H., 2000 Jan, In : European Journal of Cancer. 36, 2, p. 235-241

    Research output: Contribution to journalArticle

  31. 2001
  32. Genetic epidemiology of BRCA1 mutations in Norway

    Moller, P., Heimdal, K., Apold, J., Fredriksen, A., Åke Borg, Hovig, E., Hagen, A., Hagen, B., Pedersen, J. C. & Maehle, L., 2001, In : European Journal of Cancer. 37, 18, p. 2428-2434

    Research output: Contribution to journalArticle

  33. Prognostic importance of the soluble plasminogen activator receptor, suPAR, in plasma from rectal cancer patients

    Fernebro, E., Madsen, R. R., Mårten Fernö, Brunner, N., Pär-Ola Bendahl, Christensen, I. J., Johnson, A. & Mef Nilbert, 2001, In : European Journal of Cancer. 37, 4, p. 486-491

    Research output: Contribution to journalArticle

  34. Survival of children with liver tumours in Europe 1978--1989

    Möller, T., Garwicz, S., Corazziari, I. & Magnani, C., 2001, In : European Journal of Cancer. 37, 6, p. 744-749

    Research output: Contribution to journalArticle

  35. The BRCA1 syndrome and other inherited breast or breast-ovarian cancers in a Norwegian prospective series

    Möller, P., Åke Borg, Heimdal, K., Apold, J., Johan Vallon-Christersson, Hovig, E. & Maehle, L., 2001, In : European Journal of Cancer. 37, 8, p. 1027-1032

    Research output: Contribution to journalArticle

  36. Urokinase plasminogen activator and its inhibitor, PAI-1, in association with progression-free survival in early stage endometrial cancer

    Fredstorp-Lidebring, M., Pär-Ola Bendahl, Brunner, N., Casslén, B., Thomas Högberg, Långström-Einarsson, E., Willén, R. & Mårten Fernö, 2001, In : European Journal of Cancer. 37, 18, p. 2339-2348

    Research output: Contribution to journalArticle

  37. A hypothesis about tumour development and the clinical features of hereditary breast cancers

    H Olsson, 2001 Nov, In : European Journal of Cancer. 37, 16, p. 2023-2029

    Research output: Contribution to journalArticle

  38. 2002
  39. C-erbB-2 expression does not predict response to docetaxel or sequential methotrexate and 5-fluorouracil in advanced breast cancer

    Sjostrom, J., Collan, J., von Boguslawski, K., Franssila, K., Bengtsson, NO., Mjaaland, I., Per Malmström, Ostenstad, B., Wist, E., Valvere, V., Bergh, J., Skiold-Petterson, D., Saksela, E. & Blomqvist, C., 2002, In : European Journal of Cancer. 38, 4, p. 535-542

    Research output: Contribution to journalArticle

  40. Comment on "The frequency of breast cancer screening: results from the UKCCCR Randomised Trial"

    Ingvar Andersson, 2002, In : European Journal of Cancer. 38, 11, p. 1427-1428

    Research output: Contribution to journalDebate/Note/Editorial

  41. Cancer risks in Nordic immigrants and their offspring in Sweden

    K Hemminki & Xinjun Li, 2002 Dec, In : European Journal of Cancer. 38, 18, p. 2428-34 7 p.

    Research output: Contribution to journalArticle

  42. 2003
  43. An open randomised trial of second-line endocrine therapy in advanced breast cancer: comparison of the aromatase inhibitors letrozole and anastrozole

    Rose, C., Vtoraya, O., Pluzanska, A., Davidson, N., Gershanovich, M., Thomas, R., Johnson, S., Caicedo, JJ., Gervasio, H., Manikhas, G., Ben Ayed, F., Burdette-Radoux, S., Chaudri-Ross, HA. & Lang, R., 2003, In : European Journal of Cancer. 39, 16, p. 2318-2327

    Research output: Contribution to journalArticle

  44. Breast conservation surgery, with and without radiotherapy, in women with lymph node-negative breast cancer: a randomised clinical trial in a population with access to public mammography screening.

    Per Malmström, Holmberg, L., Anderson, H., Mattsson, J., Jönsson, P. E., Tennvall-Nittby, L., Balldin, G., Lovén, L., Svensson, J. H., Christian Ingvar, Möller, T., Holmberg, E. & Wallgren, A., 2003, In : European Journal of Cancer. 39, 12, p. 1690-1697

    Research output: Contribution to journalArticle

  45. Prognostic information in soft tissue sarcoma using tumour size, vascular invasion and microscopic tumour necrosis-the SIN-system.

    Pelle Gustafson, Åkerman, M., Thor Alvegård, Coindre, J-M., Fletcher, C. D. M., Anders Rydholm & Willén, H., 2003, In : European Journal of Cancer. 39, 11, p. 1568-1576

    Research output: Contribution to journalArticle

  46. Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer

    Luoma, ML., Hakamies-Blomqvist, L., Sjostrom, J., Pluzanska, A., Ottoson, S., Mouridsen, H., Bengtsson, NO., Bergh, J., Per Malmström, Valvere, V., Tennvall, L. & Blomqvist, C., 2003, In : European Journal of Cancer. 39, 10, p. 1370-1376

    Research output: Contribution to journalArticle

  47. Radiation dose as a risk factor for malignant melanoma following childhood cancer

    Guerin, S., Dupuy, A., Anderson, H., Shamsaldin, A., Svahn-Tapper, G., Moller, T., Quiniou, E., Garwicz, S., Hawkins, M., Avril, MF., Oberlin, O., Chavaudra, J. & de Vathaire, F., 2003, In : European Journal of Cancer. 39, 16, p. 2379-2386

    Research output: Contribution to journalArticle

  48. Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders

    Smeland, S., Muller, C., Thor Alvegård, Wiklund, T., Thomas Wiebe, Bjork, O., Stenwig, AE., Willen, H., Holmstrom, T., Folleras, G., Brosjo, O., Kivioja, A., Jonsson, K., Monge, O. & Saeter, G., 2003, In : European Journal of Cancer. 39, 4, p. 488-494

    Research output: Contribution to journalArticle

  49. Defective mismatch-repair in patients with multiple primary tumours including colorectal cancer

    Ericson, K., Halvarsson, B., Nagel, J., Rambech, E., M Planck, Piotrowska, Z., Olsson, H. & M Nilbert, 2003 Jan, In : European Journal of Cancer. 39, 2, p. 240-8 9 p.

    Research output: Contribution to journalArticle

  50. 2004
  51. An autocrine loop for vascular endothelial growth factor is established in prostate cancer cells generated after prolonged treatment with interleukin 6

    Steiner, H., Berger, AP., Godoy-Tundidor, S., Anders Bjartell, Hans Lilja, Bartsch, G., Hobisch, A. & Culig, Z., 2004, In : European Journal of Cancer. 40, 7, p. 1066-1072

    Research output: Contribution to journalArticle

  52. Association between preoperative plasma levels of tissue inhibitor of metalloproteinases 1 and rectal cancer patient survival: a validation study

    Holten-Andersen, M., Christensen, IJ., Mef Nilbert, Pär-Ola Bendahl, Nielsen, HJ., Brunner, N. & Fernebro, E., 2004, In : European Journal of Cancer. 40, 1, p. 64-72

    Research output: Contribution to journalArticle

  53. Can the survival difference between breast cancer patients in Denmark and Sweden 1989 and 1994 be explained by patho-anatomical variables? - A population-based study

    Christensen, LH., Engholm, G., Ceberg, J., Hein, S., Perfekt, R., Tange, UB., Andersson, M., Mouridsen, HT., Möller, T. & Storm, HH., 2004, In : European Journal of Cancer. 40, 8, p. 1233-1243

    Research output: Contribution to journalArticle

  54. "Good Old" clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers.

    Patrik Edén, Ritz, C., Rose, C., Mårten Fernö & Peterson, C., 2004, In : European Journal of Cancer. 40, 12, p. 1837-1841

    Research output: Contribution to journalArticle

  55. Joint effects of different human papillomaviruses and Chlamydia trachomatis infections on risk of squamous cell carcinoma of the cervix uteri

    Luostarinen, T., Lehtinen, M., Bjorge, T., Abeler, V., Hakama, M., Hallmans, G., Jellum, E., Koskela, P., Lenner, P., Lie, AK., Paavonen, J., Pukkala, E., Saikku, P., Sigstad, E., Thoresen, S., Youngman, LD., Dillner, J. & Hakulinen, T., 2004, In : European Journal of Cancer. 40, 7, p. 1058-1065

    Research output: Contribution to journalArticle

  56. Letter to the editor

    Rose, C., 2004, In : European Journal of Cancer. 40, 18, p. 2859-2859

    Research output: Contribution to journalLetter

  57. Association of brain tumours with other neoplasms in families

    K Hemminki & Xinjun Li, 2004 Jan, In : European Journal of Cancer. 40, 2, p. 253-9 7 p.

    Research output: Contribution to journalArticle

Previous 1 2 3 4 Next